GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » National Research Corp (NAS:NRC) » Definitions » EPS without NRI

National Research (National Research) EPS without NRI : $1.25 (TTM As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is National Research EPS without NRI?

National Research's earnings per share without non-recurring items for the three months ended in Dec. 2023 was $0.36. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was $1.25.

During the past 12 months, National Research's average earnings per share (NRI) Growth Rate was -7.10% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was -4.40% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 3.30% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 17.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for National Research's EPS without NRI or its related term are showing as below:

NRC' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -33.5   Med: 9.9   Max: 59.8
Current: -4.4

During the past 13 years, National Research's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 59.80% per year. The lowest was -33.50% per year. And the median was 9.90% per year.

NRC's 3-Year EPS without NRI Growth Rate is ranked worse than
67.15% of 484 companies
in the Healthcare Providers & Services industry
Industry Median: 9.1 vs NRC: -4.40

National Research's EPS (Diluted) for the three months ended in Dec. 2023 was $0.36. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $1.25.

National Research's EPS (Basic) for the three months ended in Dec. 2023 was $0.36. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $1.26.


National Research EPS without NRI Historical Data

The historical data trend for National Research's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

National Research EPS without NRI Chart

National Research Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.26 1.43 1.46 1.35 1.25

National Research Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.28 0.29 0.32 0.36

Competitive Comparison of National Research's EPS without NRI

For the Health Information Services subindustry, National Research's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


National Research's PE Ratio without NRI Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, National Research's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where National Research's PE Ratio without NRI falls into.



National Research EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


National Research  (NAS:NRC) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


National Research EPS without NRI Related Terms

Thank you for viewing the detailed overview of National Research's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


National Research (National Research) Business Description

Traded in Other Exchanges
N/A
Address
1245 Q Street, Lincoln, NE, USA, 68508
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The solutions are offered at an enterprise level through the Voice of the Customer platform, The Governance Institute, and legacy Experience solutions. It operates in the United States and Canada, of which key revenue is derived from the United States.
Executives
Amandla Mk Trust 10 percent owner C/O THE BRYN MAWR TRUST COMPANY OF DELAW, 20 MONTCHANIN RD, SUITE 100, GREENVILLE DE 19807
Common Property Trust 10 percent owner 709 PIER 2, LINCOLN NE 68528
Parul Bhandari director 1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Stephen H Lockhart director C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Penny Ann Wheeler director C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Donald M Berwick director C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Jona S Raasch officer: Vice President and COO
Kevin R Karas officer: SVP Finance, CFO, Treas & Secy C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Michael & Karen Hays Grandchildren's Trust Dated March 9, 2009 10 percent owner C/O BESSEMER TRUST COMPANY OF DELAWARE, 1007 N. ORANGE ST., SUITE 1450, WILMINGTON DE 19801
Joann M Martin director 6221 ANDREW COURT, LINCOLN NE 68512
Helen Hrdy officer: Chief Growth Officer C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Steven D. Jackson officer: President C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
John N Nunnelly director P.O. BOX 2175, AMHERST MA 01004
Barbara Mowry director P.O. BOX 103115, DENVER CO 80250
Michael Hays director, 10 percent owner, officer: President and CEO C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508